The federal government has spent $27 billion—and hospital systems have spent even more—to roll out electronic medical records across the industry. But even advocates say the results have been “disappointing.”
Dow AgroSciences reported stagnant sales in the third quarter Wednesday morning on softer sales of crop-protection products. Meanwhile, parent company Dow Chemical beat expectations with its quarterly report.
A new think tank report, which appears to jibe with Obama administration concerns, calls for “significant revision” to the Pence plan.
Enlist Duo can be used in six states, with approval pending in another 10, the Environmental Protection Agency said Wednesday. Dow is counting on the system to help double earnings at Dow AgroSciences in five to seven years.
The Hoosiers waiting for Gov. Mike Pence and President Obama to work out a deal to expand health coverage have median household incomes of less than $10,000, typically have no college education and are disproportionately minorities.
Medicare will reduce payments to 68 Indiana hospitals—a 62-percent increase from last year—for having too many patients return within 30 days.
WellPoint created an HMO joint venture with seven big hospitals in Los Angeles. Could it do something similar here? Quite possibly.
Paying off medical debts over time is now a common experience for families with health insurance and becoming more so. And that is inducing big changes in the health care marketplace.
For Indiana employers with fewer than 10 workers, health insurance premiums have risen 11.5 percent, on average, from 2001 to 2013. That ranked second-highest among all states.
As local hospitals try to offer package deals with upfront prices on joint replacement surgeries, they're struggling with the reality that patients' other health conditions can significantly increase their cost of care.
The farmers won't be able to take full advantage of the seeds until the EPA issues a second ruling allowing the use of weed killer Enlist. The EPA has said it will rule this fall on Indianapolis-based Dow AgroSciences' application to market the chemical.
Strong leadership is needed for the urban Indianapolis tech park to hit its high potential.
A new study finds that Obamacare boosted enrollment in Indiana’s individual insurance market significantly over what it would have been without the law, but also caused premiums to spike.
Lilly is finally putting meat on the bones of its predictions about its experimental diabetes and cancer drugs. That gives investors the certainty they crave that Lilly’s future revenue won’t remain in its 2014 doldrums.
Eli Lilly and Co. said Friday its potential colorectal cancer drug Cyramza helped patients on chemotherapy with advanced cases of the disease survive longer than patients on chemotherapy alone.
Conservatives, after waging war on Obamacare, including its large expansion of Medicaid, are starting to try to propose alternative, conservative ways to achieve its key goals.
Companion Diagnostics Inc., a biotech company that relocated to Indiana from Connecticut in 2010, has entered bankruptcy reorganization while it tries to develop a therapy for inflammation.
Indiana does not appear to be enjoying the rest of the nation’s slowdown in health care spending. Year-to-year growth in Indiana hit 6 percent in 2012 versus 4.5 percent for the nation.
Just three months before the parent company of AIT Laboratories was sold in 2009 to its employees for $90 million, it was appraised for $17.1 million, according to a U.S. Department of Labor lawsuit.
